Cognition Therapeutics (NASDAQ:CGTX) Price Target Lowered to $3.00 at HC Wainwright
Cognition Therapeutics (NASDAQ:CGTX – Get Free Report) had its target price reduced by investment analysts at HC Wainwright from $5.00 to $3.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. CGTX has been the topic of a number of other research reports. Brookline Capital Management […]
Cognition Therapeutics (NASDAQ:CGTX – Get Free Report) had its target price reduced by investment analysts at HC Wainwright from $5.00 to $3.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. CGTX has been the topic of a number of other research reports. Brookline Capital Management […]
